CEDAR KNOLLS, N.J.,
March 13, 2017 /PRNewswire/
-- MYOS RENS Technology Inc. ("MYOS" or "the Company") (
NASDAQ : MYOS ), today announced the launch of its much anticipated
Qurr product line, which is available for both individual product
purchase and subscription orders from the Qurr.com e-commerce site
and educational portal. Qurr products, available in delicious
powders, puddings and shakes, contain MYOS' proprietary ingredient
Fortetropin®, which is clinically shown to reduce serum
myostatin levels and increase lean muscle size and mass.
"Muscle is critical to our overall well-being and we are
thrilled to offer products developed to build healthy muscles which
provide a foundation for full-body health and overall healthy
living," said Joseph Mannello, CEO
of MYOS. "Consumers simply take one packet a day in conjunction
with resistance training, and within three months can see increases
in lean muscle mass."
Qurr products are designed for customer convenience and maximum
results. Broken up into easily transported packets and available in
four flavors, Qurr products target three distinct demographics:
- Qurr Well, which supports healthy aging by increasing
lean muscle
- Qurr Toned, for promoting healthy muscle which can lead
to a beautiful lean and toned body
- Qurr Strong, for athletes hoping to reach their most
ambitious training goals
Qurr products are powered by MYOS' proprietary ingredient,
Fortetropin®, which has been clinically shown to reduce
serum myostatin levels and increase lean muscle size and mass.
Fortetropin® is a bioactive proteo-lipid complex
containing various proteins and other bioactive molecules isolated
from fertilized egg yolk using a patented process that preserves
the biological integrity and bioactivity of the mixture.
Fortetropin® is the first safe and all-natural myostatin
reducing product available, with no adverse events reported during
any MYOS clinical studies.
"While MYOS has always offered trusted products consumers can
rely on, our product lines and science have continued to evolve,"
said Mannello. "Qurr is the natural outcome of that process.
Furthermore, we take our commitment to designing muscle health
products seriously and have constructed our website as a wellness
destination. Qurr.com will provide muscle health education
through articles, blogs, personal trainer insights, resource tools,
current news and breakthroughs, in addition to product ordering
information."
Qurr products are low calorie, naturally soy free and non-GMO,
with a recommended daily dose of 6.6 grams of
Fortetropin®. Packages start at $129.99 per month with additional savings for
monthly subscriptions or larger quantities. For more information or
to purchase Qurr, please visit www.qurr.com.
About MYOS RENS Technology Inc.
MYOS RENS Technology (MYOS), "The Muscle Company™", is a
Cedar Knolls, NJ-based
biotherapeutics and bionutrition company focused on developing
products that improve muscle health and performance and bringing
them to market. MYOS is the owner of Fortetropin®, the
world's first clinically demonstrated myostatin reducer. Myostatin
is a natural regulatory protein, which inhibits muscle growth and
recovery. Fortetropin® is manufactured to optimize
biological activity, which MYOS believes has the potential to
redefine existing standards of physical health and wellness
enhancement.
Forward-Looking Statements
Any statements in this release that are not historical facts are
forward-looking statements. Actual results may differ materially
from those projected or implied in any forward-looking statements.
Such statements involve risks and uncertainties, including but not
limited to those relating to product and customer demand, market
acceptance of our products, the ability to create new products
through research and development, the successful launch of our
products, including Qurr products, the success of our research and
development, the results of the clinical evaluation of
Fortetropin® and its effects, the ability to enter into
partnership opportunities, the ability to generate the forecasted
revenue stream and cash flow from sales of our products, the
ability to achieve a sustainable, profitable business, the effect
of economic conditions, the ability to protect our intellectual
property rights, competition from other providers and products, the
continued listing of our securities on the Nasdaq Stock Market,
risks in product development, our ability to raise capital to fund
continuing operations, and other factors discussed from time to
time in the Company's Securities and Exchange Commission filings.
The Company undertakes no obligation to update or revise any
forward-looking statement for events or circumstances after the
date on which such statement is made except as required by law.
These statements have not been evaluated by the Food and Drug
Administration. Our products are not intended to diagnose, treat,
cure or prevent any disease.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/are-you-qurr-ious-myos-rens-technology-inc-launches-qurr-product-line-powered-by-fortetropin-an-all-natural-ingredient-clinically-proven-to-increase-muscle-size-and-mass-300422198.html
SOURCE MYOS RENS Technology Inc.